Skip to content

Advertisement

Open Peer Review Reports for: Comparison of the efficacies of first-generation epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced non-small-cell lung cancer harboring EGFR mutations

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
12 Sep 2017 Submitted Original manuscript
22 Sep 2017 Author responded Author comments - naoto aiko
Resubmission - Version 2
22 Sep 2017 Submitted Manuscript version 2
21 Nov 2017 Author responded Author comments - naoto aiko
Resubmission - Version 3
21 Nov 2017 Submitted Manuscript version 3
16 Jan 2018 Reviewed Reviewer Report - Akash Patel
26 Jun 2018 Reviewed Reviewer Report - Reviewer 2
9 Aug 2018 Author responded Author comments - naoto aiko
Resubmission - Version 4
9 Aug 2018 Submitted Manuscript version 4
5 Sep 2018 Reviewed Reviewer Report - Reviewer 2
28 Sep 2018 Author responded Author comments - naoto aiko
Resubmission - Version 5
28 Sep 2018 Submitted Manuscript version 5
Publishing
8 Oct 2018 Editorially accepted
22 Oct 2018 Article published 10.1186/s12885-018-4911-7

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement